{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:48:32Z","timestamp":1759402112910,"version":"build-2065373602"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health and Welfare, Republic of Korea","award":["RS-2024-00439029"],"award-info":[{"award-number":["RS-2024-00439029"]}]},{"name":"National Research Foundation of Korea funded by the Korea government","award":["RS-2023-00217317"],"award-info":[{"award-number":["RS-2023-00217317"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17620-y","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T09:58:25Z","timestamp":1759399105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systematic metabolomic study on the plasma and urine of a mouse model of Alport syndrome"],"prefix":"10.1038","volume":"15","author":[{"given":"Hong Sang","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songjin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moongi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeongchan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Heon","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Seong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong Kwon","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man-Jeong","family":"Paik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Hui","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"17620_CR1","doi-asserted-by":"publisher","first-page":"402","DOI":"10.23876\/j.krcp.20.111","volume":"39","author":"K Nozu","year":"2020","unstructured":"Nozu, K. et al. Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome. Kidney Res. Clin. Pract. 39, 402\u2013413. https:\/\/doi.org\/10.23876\/j.krcp.20.111 (2020).","journal-title":"Kidney Res. Clin. Pract."},{"key":"17620_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s10157-018-1629-4","volume":"23","author":"K Nozu","year":"2019","unstructured":"Nozu, K. et al. A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin. Exp. Nephrol. 23, 158\u2013168. https:\/\/doi.org\/10.1007\/s10157-018-1629-4 (2019).","journal-title":"Clin. Exp. Nephrol."},{"key":"17620_CR3","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0272-6386(99)70385-9","volume":"34","author":"A Remuzzi","year":"1999","unstructured":"Remuzzi, A., Fassi, A., Bertani, T., Perico, N. & Remuzzi, G. ACE Inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. Am. J. Kidney Dis. 34, 626\u2013632. https:\/\/doi.org\/10.1016\/S0272-6386(99)70385-9 (1999).","journal-title":"Am. J. Kidney Dis."},{"key":"17620_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","volume":"63","author":"O Gross","year":"2003","unstructured":"Gross, O. et al. Preemptive Ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome. Kidney Int. 63, 438\u2013446. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00779.x (2003).","journal-title":"Kidney Int."},{"key":"17620_CR5","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1093\/ndt\/gfh219","volume":"19","author":"O Gross","year":"2004","unstructured":"Gross, O. et al. Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis. Nephrol. Dial Transpl. 19, 1716\u20131723. https:\/\/doi.org\/10.1093\/ndt\/gfh219 (2004).","journal-title":"Nephrol. Dial Transpl."},{"key":"17620_CR6","doi-asserted-by":"publisher","first-page":"682929","DOI":"10.3389\/fgene.2021.682929","volume":"12","author":"MA Govender","year":"2021","unstructured":"Govender, M. A., Brandenburg, J. T., Fabian, J. & Ramsay, M. The use of \u2018omics for diagnosing and predicting progression of chronic kidney disease: A scoping review. Front. Genet. 12, 682929. https:\/\/doi.org\/10.3389\/fgene.2021.682929 (2021).","journal-title":"Front. Genet."},{"key":"17620_CR7","doi-asserted-by":"publisher","unstructured":"Provenzano, M. et al. OMICS in chronic kidney disease: focus on prognosis and prediction. Int. J. Mol. Sci. 23. https:\/\/doi.org\/10.3390\/ijms23010336 (2021).","DOI":"10.3390\/ijms23010336"},{"key":"17620_CR8","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1681\/ASN.0000000000000343","volume":"35","author":"P Schlosser","year":"2024","unstructured":"Schlosser, P. et al. Association of integrated proteomic and metabolomic modules with risk of kidney disease progression. J. Am. Soc. Nephrol. 35, 923\u2013935. https:\/\/doi.org\/10.1681\/ASN.0000000000000343 (2024).","journal-title":"J. Am. Soc. Nephrol."},{"key":"17620_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1053\/j.ajkd.2023.05.014","volume":"83","author":"TT Geng","year":"2024","unstructured":"Geng, T. T. et al. Nuclear magnetic Resonance-Based metabolomics and risk of CKD. Am. J. Kidney Dis. 83, 9\u201317. https:\/\/doi.org\/10.1053\/j.ajkd.2023.05.014 (2024).","journal-title":"Am. J. Kidney Dis."},{"key":"17620_CR10","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1101\/gad.10.23.2981","volume":"10","author":"D Cosgrove","year":"1996","unstructured":"Cosgrove, D. et al. Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome. Genes Dev. 10, 2981\u20132992. https:\/\/doi.org\/10.1101\/gad.10.23.2981 (1996).","journal-title":"Genes Dev."},{"key":"17620_CR11","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1038\/s41598-020-61250-5","volume":"10","author":"HS Choi","year":"2020","unstructured":"Choi, H. S. et al. Angiotensin-[1\u20137] attenuates kidney injury in experimental Alport syndrome. Sci. Rep. 10, 4225. https:\/\/doi.org\/10.1038\/s41598-020-61250-5 (2020).","journal-title":"Sci. Rep."},{"key":"17620_CR12","doi-asserted-by":"publisher","DOI":"10.23876\/j.krcp.24.065","author":"E Kang","year":"2024","unstructured":"Kang, E. et al. A comprehensive review of Alport syndrome: Definition, pathophysiology, clinical manifestations, and diagnostic considerations. Kidney Res. Clin. Pract. https:\/\/doi.org\/10.23876\/j.krcp.24.065 (2024).","journal-title":"Kidney Res. Clin. Pract."},{"key":"17620_CR13","doi-asserted-by":"publisher","unstructured":"Jones, B. A. et al. NAD\u2009+\u2009prevents chronic kidney disease by activating renal tubular metabolism. JCI Insight. 10 https:\/\/doi.org\/10.1172\/jci.insight.181443 (2025).","DOI":"10.1172\/jci.insight.181443"},{"key":"17620_CR14","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/2211-5463.13568","volume":"13","author":"V Miguel","year":"2023","unstructured":"Miguel, V. & Kramann, R. Metabolic reprogramming heterogeneity in chronic kidney disease. FEBS Open. Bio. 13, 1154\u20131163. https:\/\/doi.org\/10.1002\/2211-5463.13568 (2023).","journal-title":"FEBS Open. Bio"},{"key":"17620_CR15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41467-021-21301-5","volume":"12","author":"Z Tian","year":"2021","unstructured":"Tian, Z. & Liang, M. Renal metabolism and hypertension. Nat. Commun. 12, 963. https:\/\/doi.org\/10.1038\/s41467-021-21301-5 (2021).","journal-title":"Nat. Commun."},{"key":"17620_CR16","doi-asserted-by":"publisher","unstructured":"Ge, M. et al. Metabolic Analysis and Renal Protective Effects of Linagliptin and Empagliflozin in Alport Syndrome. Kidney360 5, 1002\u20131011, (2024). https:\/\/doi.org\/10.34067\/KID.0000000000000472","DOI":"10.34067\/KID.0000000000000472"},{"key":"17620_CR17","doi-asserted-by":"publisher","unstructured":"Hasegawa, S., Jao, T. M. & Inagi, R. Dietary metabolites and chronic kidney disease. Nutrients 9 https:\/\/doi.org\/10.3390\/nu9040358 (2017).","DOI":"10.3390\/nu9040358"},{"key":"17620_CR18","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3389\/fphar.2019.00928","volume":"10","author":"L Wang","year":"2019","unstructured":"Wang, L. et al. Metabolomics study of metabolic changes in renal cells in response to High-Glucose exposure based on liquid or gas chromatography coupled with mass spectrometry. Front. Pharmacol. 10, 928. https:\/\/doi.org\/10.3389\/fphar.2019.00928 (2019).","journal-title":"Front. Pharmacol."},{"key":"17620_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41574-021-00626-7","volume":"18","author":"JA Amorim","year":"2022","unstructured":"Amorim, J. A. et al. Mitochondrial and metabolic dysfunction in ageing and age-related diseases. Nat. Rev. Endocrinol. 18, 243\u2013258. https:\/\/doi.org\/10.1038\/s41574-021-00626-7 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"17620_CR20","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.34067\/KID.0000000000000153","volume":"4","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Energy metabolism dysregulation in chronic kidney disease. Kidney360 4, 1080\u20131094. https:\/\/doi.org\/10.34067\/KID.0000000000000153 (2023).","journal-title":"Kidney360"},{"key":"17620_CR21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s42003-023-05057-w","volume":"6","author":"S Aihara","year":"2023","unstructured":"Aihara, S. et al. Spermidine from arginine metabolism activates Nrf2 and inhibits kidney fibrosis. Commun. Biol. 6, 676. https:\/\/doi.org\/10.1038\/s42003-023-05057-w (2023).","journal-title":"Commun. Biol."},{"key":"17620_CR22","doi-asserted-by":"publisher","first-page":"F487","DOI":"10.1152\/ajprenal.1999.277.4.F487","volume":"277","author":"MA Hediger","year":"1999","unstructured":"Hediger, M. A. Glutamate transporters in kidney and brain. Am. J. Physiol. 277, F487\u2013492. https:\/\/doi.org\/10.1152\/ajprenal.1999.277.4.F487 (1999).","journal-title":"Am. J. Physiol."},{"key":"17620_CR23","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3389\/fphys.2017.00902","volume":"8","author":"G Carta","year":"2017","unstructured":"Carta, G., Murru, E., Banni, S. & Manca, C. Palmitic acid: physiological role, metabolism and nutritional implications. Front. Physiol. 8, 902. https:\/\/doi.org\/10.3389\/fphys.2017.00902 (2017).","journal-title":"Front. Physiol."},{"key":"17620_CR24","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11010-019-03535-6","volume":"458","author":"A Cobbs","year":"2019","unstructured":"Cobbs, A. et al. Saturated fatty acid stimulates production of extracellular vesicles by renal tubular epithelial cells. Mol. Cell. Biochem. 458, 113\u2013124. https:\/\/doi.org\/10.1007\/s11010-019-03535-6 (2019).","journal-title":"Mol. Cell. Biochem."},{"key":"17620_CR25","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/jcp.22255","volume":"225","author":"JC Lim","year":"2010","unstructured":"Lim, J. C., Lim, S. K., Han, H. J. & Park, S. H. Cannabinoid receptor 1 mediates palmitic acid-induced apoptosis via Endoplasmic reticulum stress in human renal proximal tubular cells. J. Cell. Physiol. 225, 654\u2013663. https:\/\/doi.org\/10.1002\/jcp.22255 (2010).","journal-title":"J. Cell. Physiol."},{"key":"17620_CR26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000487673","volume":"43","author":"T Liu","year":"2018","unstructured":"Liu, T. et al. Palmitic Acid-Induced podocyte apoptosis via the reactive oxygen Species-Dependent mitochondrial pathway. Kidney Blood Press. Res. 43, 206\u2013219. https:\/\/doi.org\/10.1159\/000487673 (2018).","journal-title":"Kidney Blood Press. Res."},{"key":"17620_CR27","doi-asserted-by":"publisher","unstructured":"Onishi, A. et al. Urine 5MedC, a marker of DNA methylation, in the progression of chronic kidney disease. Dis. Markers. 2019 (5432453). https:\/\/doi.org\/10.1155\/2019\/5432453 (2019).","DOI":"10.1155\/2019\/5432453"},{"key":"17620_CR28","doi-asserted-by":"publisher","first-page":"F257","DOI":"10.1152\/ajprenal.1986.251.2.F257","volume":"251","author":"M Barac-Nieto","year":"1986","unstructured":"Barac-Nieto, M. Renal reabsorption and utilization of hydroxybutyrate and acetoacetate in starved rats. Am. J. Physiol. 251, F257\u2013265. https:\/\/doi.org\/10.1152\/ajprenal.1986.251.2.F257 (1986).","journal-title":"Am. J. Physiol."},{"key":"17620_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1079\/pns19950049","volume":"54","author":"G Baverel","year":"1995","unstructured":"Baverel, G., Ferrier, B. & Martin, M. Fuel selection by the kidney: Adaptation to starvation. Proc. Nutr. Soc. 54, 197\u2013212. https:\/\/doi.org\/10.1079\/pns19950049 (1995).","journal-title":"Proc. Nutr. Soc."},{"key":"17620_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0026-0495(75)90004-9","volume":"24","author":"DG Sapir","year":"1975","unstructured":"Sapir, D. G. & Owen, O. E. Renal conservation of ketone bodies during starvation. Metabolism 24, 23\u201333. https:\/\/doi.org\/10.1016\/0026-0495(75)90004-9 (1975).","journal-title":"Metabolism"},{"key":"17620_CR31","doi-asserted-by":"publisher","first-page":"320","DOI":"10.34067\/KID.0000000000000359","volume":"5","author":"K Yamahara","year":"2024","unstructured":"Yamahara, K., Yasuda-Yamahara, M., Kuwagata, S., Chin-Kanasaki, M. & Kume, S. Ketone body metabolism in diabetic kidney disease. Kidney360 5, 320\u2013326. https:\/\/doi.org\/10.34067\/KID.0000000000000359 (2024).","journal-title":"Kidney360"},{"key":"17620_CR32","doi-asserted-by":"publisher","first-page":"985378","DOI":"10.3389\/fimmu.2022.985378","volume":"13","author":"D Li","year":"2022","unstructured":"Li, D. et al. Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders. Front. Immunol. 13, 985378. https:\/\/doi.org\/10.3389\/fimmu.2022.985378 (2022).","journal-title":"Front. Immunol."},{"key":"17620_CR33","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1523\/JNEUROSCI.5032-08.2009","volume":"29","author":"JC O\u2019Connor","year":"2009","unstructured":"O\u2019Connor, J. C. et al. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to Bacillus Calmette-Guerin. J. Neurosci. 29, 4200\u20134209. https:\/\/doi.org\/10.1523\/JNEUROSCI.5032-08.2009 (2009).","journal-title":"J. Neurosci."},{"key":"17620_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/jir.2005.25.20","volume":"25","author":"CM Robinson","year":"2005","unstructured":"Robinson, C. M., Hale, P. T. & Carlin, J. M. The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase. J. Interferon Cytokine Res. 25, 20\u201330. https:\/\/doi.org\/10.1089\/jir.2005.25.20 (2005).","journal-title":"J. Interferon Cytokine Res."},{"key":"17620_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","volume":"25","author":"J Savitz","year":"2020","unstructured":"Savitz, J. The kynurenine pathway: A finger in every pie. Mol. Psychiatry. 25, 131\u2013147. https:\/\/doi.org\/10.1038\/s41380-019-0414-4 (2020).","journal-title":"Mol. Psychiatry"},{"key":"17620_CR36","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1159\/000519811","volume":"52","author":"HN Wee","year":"2021","unstructured":"Wee, H. N., Liu, J. J., Ching, J., Kovalik, J. P. & Lim, S. C. The kynurenine pathway in acute kidney injury and chronic kidney disease. Am. J. Nephrol. 52, 771\u2013787. https:\/\/doi.org\/10.1159\/000519811 (2021).","journal-title":"Am. J. Nephrol."},{"key":"17620_CR37","doi-asserted-by":"publisher","first-page":"113551","DOI":"10.1016\/j.jpba.2020.113551","volume":"191","author":"YR Ma","year":"2020","unstructured":"Ma, Y. R. et al. An LC-MS\/MS analytical method for the determination of uremic toxins in patients with end-stage renal disease. J. Pharm. Biomed. Anal. 191, 113551. https:\/\/doi.org\/10.1016\/j.jpba.2020.113551 (2020).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"17620_CR38","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","volume":"63","author":"R Vanholder","year":"2003","unstructured":"Vanholder, R. et al. Review on uremic toxins: Classification, concentration, and interindividual variability. Kidney Int. 63, 1934\u20131943. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00924.x (2003).","journal-title":"Kidney Int."},{"key":"17620_CR39","doi-asserted-by":"publisher","first-page":"e98581","DOI":"10.1371\/journal.pone.0098581","volume":"9","author":"H Hur","year":"2014","unstructured":"Hur, H. et al. Quantitative measurement of organic acids in tissues from gastric cancer patients indicates increased glucose metabolism in gastric cancer. PLoS One. 9, e98581 (2014).","journal-title":"PLoS One"},{"key":"17620_CR40","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/bmc.966","volume":"22","author":"MJ Paik","year":"2008","unstructured":"Paik, M. J. et al. Simultaneous clinical monitoring of lactic acid, pyruvic acid and ketone bodies in plasma as methoxime\/tert-butyldimethylsilyl derivatives by gas chromatography\u2013mass spectrometry in selected ion monitoring mode. Biomed. Chromatogr. 22, 450\u2013453 (2008).","journal-title":"Biomed. Chromatogr."},{"key":"17620_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.chroma.2004.02.032","volume":"1034","author":"MJ Paik","year":"2004","unstructured":"Paik, M. J. & Kim, K. R. Sequential ethoxycarbonylation, methoximation and tert-butyldimethylsilylation for simultaneous determination of amino acids and carboxylic acids by dual-column gas chromatography. J. Chromatogr. A. 1034, 13\u201323 (2004).","journal-title":"J. Chromatogr. A"},{"key":"17620_CR42","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11306-016-1125-3","volume":"12","author":"C Seo","year":"2016","unstructured":"Seo, C., Park, M., Choi, B., Lee, S. & Paik, M. J. Metabolomic analysis of urinary organic acids following intraperitoneal injection with \u03b3-hydroxybutyric acid in rats. Metabolomics 12, 190. https:\/\/doi.org\/10.1007\/s11306-016-1125-3 (2016).","journal-title":"Metabolomics"},{"key":"17620_CR43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11306-019-1574-6","volume":"15","author":"C Seo","year":"2019","unstructured":"Seo, C. et al. Metabolomic study on bleomycin and polyhexamethylene guanidine phosphate-induced pulmonary fibrosis mice models. Metabolomics 15, 111 (2019).","journal-title":"Metabolomics"},{"key":"17620_CR44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11306-020-01737-4","volume":"16","author":"Y Kim","year":"2020","unstructured":"Kim, Y. et al. Metabolomic analysis of organic acids, amino acids, and fatty acids in plasma of Hanwoo beef on a high-protein diet. Metabolomics 16, 114 (2020).","journal-title":"Metabolomics"},{"key":"17620_CR45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11306-018-1409-x","volume":"14","author":"C Seo","year":"2018","unstructured":"Seo, C. et al. Monitoring of altered amino acid metabolic pattern in rat urine following intraperitoneal injection with \u03b3-hydroxybutyric acid. Metabolomics 14, 111 (2018).","journal-title":"Metabolomics"},{"key":"17620_CR46","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/00032719.2019.1656728","volume":"53","author":"C Seo","year":"2020","unstructured":"Seo, C. et al. Simultaneous determination of 35 organic metabolites including amino acids, creatine, creatinine, and oxidized and reduced glutathione in lung tissue, plasma and urine using liquid Chromatography\u2013Tandem mass spectrometry. Anal. Lett. 53, 469\u2013481. https:\/\/doi.org\/10.1080\/00032719.2019.1656728 (2020).","journal-title":"Anal. Lett."},{"key":"17620_CR47","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/metabo10110436","volume":"10","author":"RY Choi","year":"2020","unstructured":"Choi, R. Y., Ji, M., Lee, M. K. & Paik, M. J. Metabolomics study of serum from a chronic alcohol-fed rat model following administration of defatted tenebrio molitor larva fermentation extract. Metabolites 10, 436 (2020).","journal-title":"Metabolites"},{"key":"17620_CR48","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3390\/biomedicines10071669","volume":"10","author":"M Ji","year":"2022","unstructured":"Ji, M. et al. Plasma metabolomics and machine Learning-Driven novel diagnostic signature for Non-Alcoholic steatohepatitis. Biomedicines 10, 1669 (2022).","journal-title":"Biomedicines"},{"key":"17620_CR49","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.3390\/ijms23052748","volume":"23","author":"HY Kim","year":"2022","unstructured":"Kim, H. Y. et al. Comprehensive targeted metabolomic study in the lung, plasma, and urine of PPE\/LPS-induced COPD mice model. Int. J. Mol. Sci. 23, 2748 (2022).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17620-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17620-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17620-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T09:58:26Z","timestamp":1759399106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17620-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17620"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17620-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee of Chonnam National University Medical School and conducted in accordance with the institutional guidelines for experimental animal care and use (CNU IACUC-H-2020-1).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"34452"}}